Emerging in the landscape of excess body fat therapy, retatrutide is a unique strategy. Unlike many current medications, retatrutide works as a twin agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) sensors. This concurrent stimulation promotes various advantageous effects, suc… Read More